Publications found:
58,333
Sort by:
Nasopharyngitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF NASOPHARYNGITIS PIPELINE REPORT INCLUDES Panorama of Nasopharyngitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Nephroblastoma (Wilms' Tumor) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF NEPHROBLASTOMA (WILMS' TUMOR) PIPELINE REPORT INCLUDES Panorama of Nephroblastoma (Wilms' Tumor) pipeline markets including statistics on therapeutic drugs and companies involved Nephroblastoma (Wilms' Tumor) Pipeline candidates across various development ...
August 2018
40 pages
Nephrotic Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF NEPHROTIC SYNDROME PIPELINE REPORT INCLUDES Panorama of Nephrotic Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Nephrotic Syndrome Pipeline candidates across various development ...
August 2018
40 pages
Neurofibromatoses (Type II) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF NEUROFIBROMATOSES (TYPE II) PIPELINE REPORT INCLUDES Panorama of Neurofibromatoses (Type II) pipeline markets including statistics on therapeutic drugs and companies involved Neurofibromatoses (Type II) Pipeline candidates across various development ...
August 2018
40 pages
Neurofibromatoses R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF NEUROFIBROMATOSES PIPELINE REPORT INCLUDES Panorama of Neurofibromatoses pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Neurofibromatoses(Type I) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF NEUROFIBROMATOSES(TYPE I) PIPELINE REPORT INCLUDES Panorama of Neurofibromatoses(Type I) pipeline markets including statistics on therapeutic drugs and companies involved Neurofibromatoses(Type I) Pipeline candidates across various development ...
August 2018
40 pages
Neuromyelitis Optica R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF NEUROMYELITIS OPTICA PIPELINE REPORT INCLUDES Panorama of Neuromyelitis Optica pipeline markets including statistics on therapeutic drugs and companies involved Neuromyelitis Optica Pipeline candidates across various development ...
August 2018
80 pages
Neutropenia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF NEUTROPENIA PIPELINE REPORT INCLUDES Panorama of Neutropenia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
80 pages
Nicotine Addiction R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF NICOTINE ADDICTION PIPELINE REPORT INCLUDES Panorama of Nicotine Addiction pipeline markets including statistics on therapeutic drugs and companies involved Nicotine Addiction Pipeline candidates across various development ...
August 2018
50 pages
Nocturia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF NOCTURIA PIPELINE REPORT INCLUDES Panorama of Nocturia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
20 pages
Non Muscle Invasive Bladder Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF NON MUSCLE INVASIVE BLADDER CANCER PIPELINE REPORT INCLUDES Panorama of Non Muscle Invasive Bladder Cancer pipeline markets including statistics on therapeutic drugs and companies involved Non Muscle Invasive Bladder Cancer Pipeline candidates across ...
August 2018
150 pages
Obsessive Compulsive Disorder R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF OBSESSIVE COMPULSIVE DISORDER PIPELINE REPORT INCLUDES Panorama of Obsessive Compulsive Disorder pipeline markets including statistics on therapeutic drugs and companies involved Obsessive Compulsive Disorder Pipeline candidates across various development ...
August 2018
30 pages
Obstructive Sleep Apnea R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF OBSTRUCTIVE SLEEP APNEA PIPELINE REPORT INCLUDES Panorama of Obstructive Sleep Apnea pipeline markets including statistics on therapeutic drugs and companies involved Obstructive Sleep Apnea Pipeline candidates across various development ...
August 2018
40 pages
Ocular Hypertension R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF OCULAR HYPERTENSION PIPELINE REPORT INCLUDES Panorama of Ocular Hypertension pipeline markets including statistics on therapeutic drugs and companies involved Ocular Hypertension Pipeline candidates across various development ...
August 2018
100 pages
Ocular Pain R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF OCULAR PAIN PIPELINE REPORT INCLUDES Panorama of Ocular Pain pipeline markets including statistics on therapeutic drugs and companies involved Ocular Pain Pipeline candidates across various development ...
August 2018
60 pages
Oligodendroglioma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF OLIGODENDROGLIOMA PIPELINE REPORT INCLUDES Panorama of Oligodendroglioma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
120 pages
Onychomycosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF ONYCHOMYCOSIS PIPELINE REPORT INCLUDES Panorama of Onychomycosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Opioid Induced Bowel Dysfunction R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF OPIOID INDUCED BOWEL DYSFUNCTION PIPELINE REPORT INCLUDES Panorama of Opioid Induced Bowel Dysfunction pipeline markets including statistics on therapeutic drugs and companies involved Opioid Induced Bowel Dysfunction Pipeline candidates across ...
August 2018
20 pages
Opioid Induced Constipation (OIC) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF OPIOID INDUCED CONSTIPATION (OIC) PIPELINE REPORT INCLUDES Panorama of Opioid Induced Constipation (OIC) pipeline markets including statistics on therapeutic drugs and companies involved Opioid Induced Constipation (OIC) Pipeline candidates across ...
August 2018
50 pages
Opium Addiction R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF OPIUM ADDICTION PIPELINE REPORT INCLUDES Panorama of Opium Addiction pipeline markets including statistics on therapeutic drugs and companies involved Opium Addiction Pipeline candidates across various development ...
August 2018
90 pages
Optic Neuritis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF OPTIC NEURITIS PIPELINE REPORT INCLUDES Panorama of Optic Neuritis pipeline markets including statistics on therapeutic drugs and companies involved Optic Neuritis Pipeline candidates across various development ...
August 2018
40 pages
Optic Neuropathy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF OPTIC NEUROPATHY PIPELINE REPORT INCLUDES Panorama of Optic Neuropathy pipeline markets including statistics on therapeutic drugs and companies involved Optic Neuropathy Pipeline candidates across various development ...
August 2018
50 pages
Oral Mucositis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF ORAL MUCOSITIS PIPELINE REPORT INCLUDES Panorama of Oral Mucositis pipeline markets including statistics on therapeutic drugs and companies involved Oral Mucositis Pipeline candidates across various development ...
August 2018
80 pages
Ornithine Transcarbamylase Deficiency R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY PIPELINE REPORT INCLUDES Panorama of Ornithine Transcarbamylase Deficiency pipeline markets including statistics on therapeutic drugs and companies involved Ornithine Transcarbamylase Deficiency Pipeline candidates across various development ...
August 2018
30 pages
Oropharyngeal Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF OROPHARYNGEAL CANCER PIPELINE REPORT INCLUDES Panorama of Oropharyngeal Cancer pipeline markets including statistics on therapeutic drugs and companies involved Oropharyngeal Cancer Pipeline candidates across various development ...
August 2018
210 pages
Osteogenesis Imperfecta R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF OSTEOGENESIS IMPERFECTA PIPELINE REPORT INCLUDES Panorama of Osteogenesis Imperfecta pipeline markets including statistics on therapeutic drugs and companies involved Osteogenesis Imperfecta Pipeline candidates across various development ...
August 2018
40 pages
Osteomyelitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF OSTEOMYELITIS PIPELINE REPORT INCLUDES Panorama of Osteomyelitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Osteonecrosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF OSTEONECROSIS PIPELINE REPORT INCLUDES Panorama of Osteonecrosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Otitis Media R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF OTITIS MEDIA PIPELINE REPORT INCLUDES Panorama of Otitis Media pipeline markets including statistics on therapeutic drugs and companies involved Otitis Media Pipeline candidates across various development ...
August 2018
60 pages
Overactive Bladder R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF OVERACTIVE BLADDER PIPELINE REPORT INCLUDES Panorama of Overactive Bladder pipeline markets including statistics on therapeutic drugs and companies involved Overactive Bladder Pipeline candidates across various development ...
August 2018
90 pages
Pancreatic Ductal Adenocarcinoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PANCREATIC DUCTAL ADENOCARCINOMA PIPELINE REPORT INCLUDES Panorama of Pancreatic Ductal Adenocarcinoma pipeline markets including statistics on therapeutic drugs and companies involved Pancreatic Ductal Adenocarcinoma Pipeline candidates across various development ...
August 2018
200 pages
Pancreatitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF PANCREATITIS PIPELINE REPORT INCLUDES Panorama of Pancreatitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Papillary Thyroid Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PAPILLARY THYROID CANCER PIPELINE REPORT INCLUDES Panorama of Papillary Thyroid Cancer pipeline markets including statistics on therapeutic drugs and companies involved Papillary Thyroid Cancer Pipeline candidates across various development ...
August 2018
60 pages
Paroxysmal Nocturnal Hemoglobinuria R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PIPELINE REPORT INCLUDES Panorama of Paroxysmal Nocturnal Hemoglobinuria pipeline markets including statistics on therapeutic drugs and companies involved Paroxysmal Nocturnal Hemoglobinuria Pipeline candidates across various development ...
August 2018
80 pages
Peanut Allergy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PEANUT ALLERGY PIPELINE REPORT INCLUDES Panorama of Peanut Allergy pipeline markets including statistics on therapeutic drugs and companies involved Peanut Allergy Pipeline candidates across various development ...
August 2018
90 pages
Pemphigus Vulgaris R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PEMPHIGUS VULGARIS PIPELINE REPORT INCLUDES Panorama of Pemphigus Vulgaris pipeline markets including statistics on therapeutic drugs and companies involved Pemphigus Vulgaris Pipeline candidates across various development ...
August 2018
50 pages
Peptic Ulcers R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PEPTIC ULCERS PIPELINE REPORT INCLUDES Panorama of Peptic Ulcers pipeline markets including statistics on therapeutic drugs and companies involved Peptic Ulcers Pipeline candidates across various development ...
August 2018
40 pages
Periodontitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF PERIODONTITIS PIPELINE REPORT INCLUDES Panorama of Periodontitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... use format. SCOPE OF PERIPHERAL NERVE SHEATH TUMOR (NEUROFIBROSARCOMA) PIPELINE REPORT INCLUDES Panorama of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) pipeline markets including statistics on therapeutic drugs and companies involved Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Pipeline candidates ...
August 2018
120 pages
Peripheral Neuropathy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PERIPHERAL NEUROPATHY PIPELINE REPORT INCLUDES Panorama of Peripheral Neuropathy pipeline markets including statistics on therapeutic drugs and companies involved Peripheral Neuropathy Pipeline candidates across various development ...
August 2018
50 pages
Peripheral T Cell Lymphomas (PTCL) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF PERIPHERAL T CELL LYMPHOMAS (PTCL) PIPELINE REPORT INCLUDES Panorama of Peripheral T Cell Lymphomas (PTCL) pipeline markets including statistics on therapeutic drugs and companies involved Peripheral T Cell Lymphomas (PTCL) Pipeline candidates across ...
August 2018
200 pages
Peritonitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF PERITONITIS PIPELINE REPORT INCLUDES Panorama of Peritonitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Pertussis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF PERTUSSIS PIPELINE REPORT INCLUDES Panorama of Pertussis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
70 pages
Phenylketonuria R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF PHENYLKETONURIA PIPELINE REPORT INCLUDES Panorama of Phenylketonuria pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Pheochromocytoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF PHEOCHROMOCYTOMA PIPELINE REPORT INCLUDES Panorama of Pheochromocytoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
80 pages
Pigmented Villonodular Synovitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PIGMENTED VILLONODULAR SYNOVITIS PIPELINE REPORT INCLUDES Panorama of Pigmented Villonodular Synovitis pipeline markets including statistics on therapeutic drugs and companies involved Pigmented Villonodular Synovitis Pipeline candidates across various development ...
August 2018
40 pages
Pituitary ACTH Hypersecretion (Cushing's Disease) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... use format. SCOPE OF PITUITARY ACTH HYPERSECRETION (CUSHING'S DISEASE) PIPELINE REPORT INCLUDES Panorama of Pituitary ACTH Hypersecretion (Cushing's Disease) pipeline markets including statistics on therapeutic drugs and companies involved Pituitary ACTH Hypersecretion (Cushing's Disease) Pipeline candidates ...
August 2018
40 pages
Plague Disease R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PLAGUE DISEASE PIPELINE REPORT INCLUDES Panorama of Plague Disease pipeline markets including statistics on therapeutic drugs and companies involved Plague Disease Pipeline candidates across various development ...
August 2018
60 pages
Poliomyelitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF POLIOMYELITIS PIPELINE REPORT INCLUDES Panorama of Poliomyelitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
